Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study.

Husebø GR, Nielsen R, Hardie J, Bakke PS, Lerner L, D'Alessandro-Gabazza C, Gyuris J, Gabazza E, Aukrust P, Eagan T.

Respir Med. 2019 Jun;152:81-88. doi: 10.1016/j.rmed.2019.04.019. Epub 2019 Apr 30.

PMID:
31128615
2.

Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.

You AS, Kalantar-Zadeh K, Lerner L, Nakata T, Lopez N, Lou L, Veliz M, Soohoo M, Jing J, Zaldivar F, Gyuris J, Nguyen DV, Rhee CM.

Cardiorenal Med. 2017 Feb;7(2):158-168. doi: 10.1159/000455907. Epub 2017 Feb 2.

3.

Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.

Husebø GR, Grønseth R, Lerner L, Gyuris J, Hardie JA, Bakke PS, Eagan TM.

Eur Respir J. 2017 Mar 15;49(3). pii: 1601298. doi: 10.1183/13993003.01298-2016. Print 2017 Mar.

4.

Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss.

Lerner L, Gyuris J, Nicoletti R, Gifford J, Krieger B, Jatoi A.

Oncol Lett. 2016 Nov;12(5):4219-4223. Epub 2016 Sep 23.

5.

MAP3K11/GDF15 axis is a critical driver of cancer cachexia.

Lerner L, Tao J, Liu Q, Nicoletti R, Feng B, Krieger B, Mazsa E, Siddiquee Z, Wang R, Huang L, Shen L, Lin J, Vigano A, Chiu MI, Weng Z, Winston W, Weiler S, Gyuris J.

J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):467-82. doi: 10.1002/jcsm.12077. Epub 2015 Oct 29.

6.

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients.

Lerner L, Hayes TG, Tao N, Krieger B, Feng B, Wu Z, Nicoletti R, Chiu MI, Gyuris J, Garcia JM.

J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):317-24. doi: 10.1002/jcsm.12033. Epub 2015 Apr 30.

7.

23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal Toxicity.

Proia T, Jiang F, Bell A, Nicoletti R, Kong L, Kreuter K, Poling L, Winston WM, Flaherty M, Weiler S, Perino S, O'Hagan R, Lin J, Gyuris J, Okamura H.

Mol Cancer Ther. 2015 Aug;14(8):1858-67. doi: 10.1158/1535-7163.MCT-14-1104. Epub 2015 May 20.

8.

Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.

Meetze K, Vincent S, Tyler S, Mazsa EK, Delpero AR, Bottega S, McIntosh D, Nicoletti R, Winston WM, Weiler S, Feng B, Gyuris J, Weng Z.

Clin Cancer Res. 2015 Mar 1;21(5):1106-14. doi: 10.1158/1078-0432.CCR-14-2407. Epub 2014 Dec 26.

9.

[Cerebral venous and sinus thrombosis].

Gyuris J.

Ideggyogy Sz. 2014 Jul 30;67(7-8):272-5. Hungarian. No abstract available.

PMID:
25509369
10.

Microenvironment-derived HGF overcomes genetically determined sensitivity to anti-MET drugs.

Pennacchietti S, Cazzanti M, Bertotti A, Rideout WM 3rd, Han M, Gyuris J, Perera T, Comoglio PM, Trusolino L, Michieli P.

Cancer Res. 2014 Nov 15;74(22):6598-609. doi: 10.1158/0008-5472.CAN-14-0761. Epub 2014 Sep 12.

11.

[The first psychotic episode].

Gyuris J.

Psychiatr Hung. 2012;27(6):459-63. Hungarian.

PMID:
23429340
12.

[Neurological and psychiatrical aspects of urine incontinence].

Gyuris J.

Ideggyogy Sz. 2012 Mar 30;65(3-4):127-30. Hungarian. No abstract available.

PMID:
23136732
13.
14.

[Aggression in psychiatric disorders].

Gyuris J.

Psychiatr Hung. 2011;26(6):434-43. Review. Hungarian.

PMID:
22354702
15.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Cell Biol. 2011 Dec;Chapter 17:Unit 17.3.. doi: 10.1002/0471143030.cb1703s53.

PMID:
22161546
16.

[Neuropsychiatry--in Hungary and in other countries].

Gyuris J.

Ideggyogy Sz. 2011 Mar 30;64(5-6):208-10. Hungarian. No abstract available.

PMID:
21692276
17.

[Psychiatric aspects of autocastration].

Gyuris J.

Psychiatr Hung. 2011;26(2):128-31. Review. Hungarian.

PMID:
21653998
18.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Neurosci. 2011 Apr;Chapter 4:Unit 4.4. doi: 10.1002/0471142301.ns0404s55.

PMID:
21462161
19.

[Neurologic and psychiatric implications of apathy].

Gyuris J.

Ideggyogy Sz. 2010 Jul 30;63(7-8):220-5. Review. Hungarian.

PMID:
20812449
20.

GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling.

Bai A, Meetze K, Vo NY, Kollipara S, Mazsa EK, Winston WM, Weiler S, Poling LL, Chen T, Ismail NS, Jiang J, Lerner L, Gyuris J, Weng Z.

Cancer Res. 2010 Oct 1;70(19):7630-9. doi: 10.1158/0008-5472.CAN-10-1489. Epub 2010 Aug 13.

21.

[Punishment or benefit: chemical castration].

Gyuris J.

Orv Hetil. 2010 May 30;151(22):907-10. doi: 10.1556/OH.2010.HO2252. Hungarian. No abstract available.

PMID:
20478813
22.

[Sexological problems in neurological disorders: neurosexology].

Gyuris J.

Ideggyogy Sz. 2009 Sep 30;62(9-10):292-7. Review. Hungarian.

PMID:
19835270
23.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Protein Sci. 2009 Aug;Chapter 19:Unit19.2. doi: 10.1002/0471140864.ps1902s57.

PMID:
19688737
24.

[Sexual dysfunctions in psychiatric disorders].

Gyuris J.

Psychiatr Hung. 2009;24(6):464-6. Hungarian. No abstract available.

PMID:
20480961
25.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Gyuris J, Brent R.

Curr Protoc Neurosci. 2001 May;Chapter 4:Unit 4.4. doi: 10.1002/0471142301.ns0404s00.

PMID:
18802916
26.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Protein Sci. 2001 May;Chapter 19:Unit19.2. doi: 10.1002/0471140864.ps1902s14.

PMID:
18429144
27.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Mol Biol. 2008 Apr;Chapter 20:Unit 20.1. doi: 10.1002/0471142727.mb2001s82.

PMID:
18425763
28.

Conversion of mRNA into double-stranded cDNA.

Klickstein LB, Neve RL, Golemis EA, Gyuris J.

Curr Protoc Mol Biol. 2001 May;Chapter 5:Unit5.5. doi: 10.1002/0471142727.mb0505s29.

PMID:
18265249
29.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Mol Biol. 2001 May;Chapter 20:Unit 20.1. doi: 10.1002/0471142727.mb2001s46.

PMID:
18265190
30.

Interaction trap/two-hybrid system to identify interacting proteins.

Golemis EA, Serebriiskii I, Finley RL Jr, Kolonin MG, Gyuris J, Brent R.

Curr Protoc Cell Biol. 2001 May;Chapter 17:Unit 17.3. doi: 10.1002/0471143030.cb1703s08.

31.

p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion.

Tsui LV, Camrud A, Mondesire J, Carlson P, Zayek N, Camrud L, Donahue B, Bauer S, Lin A, Frey D, Rivkin M, Subramanian A, Falotico R, Gyuris J, Schwartz R, McArthur JG.

Circ Res. 2001 Aug 17;89(4):323-8.

PMID:
11509448
32.

p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia.

McArthur JG, Qian H, Citron D, Banik GG, Lamphere L, Gyuris J, Tsui L, George SE.

Mol Ther. 2001 Jan;3(1):8-13.

33.

Novel chimeric p16 and p27 molecules with increased antiproliferative activity for vascular disease gene therapy.

Lamphere L, Tsui L, Wick S, Nakano T, Kilinski L, Finer M, McArthur J, Gyuris J.

J Mol Med (Berl). 2000;78(8):451-9.

PMID:
11097114
34.

The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.

Patel SD, Tran AC, Ge Y, Moskalenko M, Tsui L, Banik G, Tom W, Scott M, Chen L, Van Roey M, Rivkin M, Mendez M, Gyuris J, McArthur JG.

Mol Ther. 2000 Aug;2(2):161-9.

35.

Interaction between Cdc37 and Cdk4 in human cells.

Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, Draetta GF, Gyuris J.

Oncogene. 1997 Apr 24;14(16):1999-2004.

36.

Dimerization of the human papillomavirus E7 oncoprotein in vivo.

Clemens KE, Brent R, Gyuris J, Münger K.

Virology. 1995 Dec 1;214(1):289-93.

37.

APC binds to the novel protein EB1.

Su LK, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B, Kinzler KW.

Cancer Res. 1995 Jul 15;55(14):2972-7.

38.
39.

Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Zervos AS, Gyuris J, Brent R.

Cell. 1994 Oct 21;79(2):following 388. No abstract available.

PMID:
7954804
40.

[Spinal metastasis from ovarian granulosa cell tumor--after 23 years].

Gyuris J, Poller I, Felber M.

Orv Hetil. 1994 Jul 31;135(31):1701-3. Hungarian.

PMID:
8065749
41.

Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein.

Cuomo CA, Kirch SA, Gyuris J, Brent R, Oettinger MA.

Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6156-60.

42.

Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.

Gyuris J, Golemis E, Chertkov H, Brent R.

Cell. 1993 Nov 19;75(4):791-803.

PMID:
8242750
43.

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B.

Nature. 1993 Apr 29;362(6423):857-60.

PMID:
8479525
44.
45.

Complex interaction of yeast nuclear proteins with the enhancer/promoter region of SV40.

Gyuris J, Dencsö L, Polyák K, Duda E.

Curr Genet. 1991 Nov;20(5):359-63.

PMID:
1666981
46.

Positive and negative control of nod gene expression in Rhizobium meliloti is required for optimal nodulation.

Kondorosi E, Gyuris J, Schmidt J, John M, Duda E, Hoffmann B, Schell J, Kondorosi A.

EMBO J. 1989 May;8(5):1331-40.

47.

[Disulfiram (anticol) psychoses].

Gyuris J, Szalay A.

Orv Hetil. 1986 Oct 5;127(40):2435-7. Hungarian. No abstract available.

PMID:
3537906
49.

[Causal connection or coincidence?].

Gyuris J, Halics E.

Orv Hetil. 1986 Feb 23;127(8):490. Hungarian. No abstract available.

PMID:
3951864
50.

[Eating epilepsy].

Gyuris J, Csémi K.

Orv Hetil. 1984 Nov 25;125(48):2937-9. Hungarian. No abstract available.

PMID:
6514340

Supplemental Content

Loading ...
Support Center